NCT06244719

Brief Summary

The goal of this clinical trial is to investigate upper-extremity vibrotactile stimulation with wearables in stroke patients. The main questions it aims to answer are: Are the wearables well-tolerated by patients? Does the vibrotactile stimulation help regain arm function? Participants will wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy. Researchers will compare the treatment group (vibrotactile stimulation wearables) with a control group (conventional therapy only) to see the effects of the vibrotactile stimulation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at P25-P50 for phase_1 stroke

Timeline
Completed

Started Feb 2024

Shorter than P25 for phase_1 stroke

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

February 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2025

Completed
Last Updated

April 11, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

January 29, 2024

Last Update Submit

April 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM)

    An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. Scores are between 0 and 66.

    Baseline, End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).

Secondary Outcomes (4)

  • Number of participants with at least one adverse event

    End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).

  • Number of participants who completed the therapy

    End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).

  • Number of participants who tolerated the vibrotactile stimulation therapy

    End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).

  • Change in the modified Ashworth scale

    Baseline, End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).

Study Arms (2)

Vibrotactile Stimulation

EXPERIMENTAL

Participants wear vibrotactile stimulation shirts and gloves for 5 hours per day, 7 days per week, during their stay at the rehabilitation unit, which is expected to be between 2-3 weeks. Participants wear the devices after conventional therapy is done for the day.

Device: Vibrotactile Stimulation

Control

NO INTERVENTION

Participants undergo conventional therapy only.

Interventions

Shirts contain embedded vibration motors that stimulate the impaired upper-extremity at 18 different locations. The gloves stimulates the fingertips.

Vibrotactile Stimulation

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients at rehabilitation units
  • Unilateral left or right sided ischemic stroke within the previous 2 weeks
  • Have Upper-Extremity Fugl-Meyer scores between 6 and 58
  • Have at least 20 degrees of active shoulder elevation and elbow flexion
  • Expected to stay 1-3 weeks in the rehabilitation unit

You may not qualify if:

  • Under anti-spasticity therapy
  • Patients that are dependent on pacemakers
  • Patients that have defibrillators
  • Have lymphedema or AV fistula for dialysis on an arm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UCHealth Rehabilitation Unit

Aurora, Colorado, 80045, United States

RECRUITING

Broomfield Hospital

Broomfield, Colorado, 80021, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Mazen Al Borno, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2024

First Posted

February 6, 2024

Study Start

February 2, 2024

Primary Completion

February 2, 2025

Study Completion

February 2, 2025

Last Updated

April 11, 2024

Record last verified: 2024-04

Locations